Glaucoma Device Demonstrated

Seeing Machines Limited
08 May 2007





8 May 2007

                            Seeing Machines Limited

                      ('Seeing Machines' or the 'Company')



             SEEING MACHINES DEMONSTRATES GLAUCOMA DEVICE AT ARVO


Seeing Machines (AIM: SEE), a leading developer of advanced computer based
imaging software systems, announces today that the Company is demonstrating the
TrueField Analyzer(R) at the Association for Research in Vision and Ophthmalogy
(ARVO) Annual Meeting in Florida from May 6-9 2007.  The TrueField Analyzer(R)
is the Company's revolutionary new medical device to assist doctors in detecting
and managing glaucoma and other eye diseases.


Seeing Machines is attending ARVO with the Company's key research partners from
the Research School of Biological Sciences at the Australian National
University.


The ARVO appearance of the TrueField Analyzer(R) is the first public
demonstration of the device to the general Ophthmalogy community.  The
Ophthmalogy market will be the key market for the device when it is released
commercially.


Nick Cerneaz, CEO of Seeing Machines, commented: 'Attending this conference is
very exciting for all those who have worked on the development of TrueField and
it's exciting for us to be showing the device to its intended users and getting
their feedback on our progress to date.'


Further information about the TrueField Analyzer(R) can be obtained from the web
site: www.truefield-analyzer.com.  Further information about Seeing Machines can
be obtained from the company website www.seeingmachines.com.


--- ENDS ---



Enquiries:
Seeing Machines Limited                  Insinger de Beaufort                Parkgreen Communications
Nick Cerneaz, CEO                        Peter Ward                          Victoria Thomas
[phone]                      [phone]                [phone]
www.seeingmachines.com



Notes to editors:


About Seeing Machines


Seeing Machines is an award winning Technology Company which focuses on vision
based human machine interfaces.  Formed in 2000 in Canberra, Australia, Seeing
Machines' purpose is to commercialise its computer-vision across a range of
industries and applications.

Seeing Machines deliver advanced computer vision solutions for researches and
developers in human factors, transportation safety, computer human interaction,
robotics, medical research and psychology.  The flagship product faceLAB(TM)
provides an automated and contact-free gaze and head tracking technology, it
solves the problem of observing human behaviour naturally, non-intrusively and
with a high degree of accuracy and usability.  Building on these unique face
tracking and pupil measurement and monitoring capabilities, the TrueField
Analyzer(R) is a development undertaken by Seeing Machines in partnership with
colleagues from the Research School of Biological Sciences (RSBS) at the
Australian National University (ANU).

The TrueField Analyzer(R) offers a new objective method to help doctors diagnose
and manage a range of eye diseases including glaucoma, age related macular
degeneration and diabetic retinopathy.   Glaucoma affects about 2-3% of the
population over 40 years of age and is a leading source of blindness.   Unlike
most other devices available to the clinician the TrueField Analyzer is a
completely objective test and it is quick and easy for patients and technicians
alike.  The device measures both eyes concurrently and due to the reliability
that arises from the objective nature of the test, it has the potential to
become a new 'gold standard' in the measurement of visual field defects and thus
in the diagnosis and management of disease such as glaucoma.

Seeing Machines' faceLAB(TM) product is a computer vision system that is able to
measure the orientation and position of a human head, as well as detect blinks
and estimate gaze-direction. It achieves all of this completely visually through
a stereo camera system connected to advanced image processing software, with no
attachments required on the subject.  The product is designed to allow human
factors researchers and designers assess the interaction of an operator in an
environment and this finds application in designing operator environments, such
as cockpits for cars, trucks, trains, and aeroplanes for instance, and other
industrial design applications, as well as medical and psychological research
situations.  The technology also has application in monitoring automobile
drivers and if it detects drowsiness or that the driver is distracted and their
attention has been diverted from the road, an alarm can be raised to alert the
driver to either pull over and rest in the case of drowsiness or to pay more
attention to the road.

faceLAB(TM) works in real-time, enabling the behaviour of a subject to be
tracked. This technology is paving the way in promoting safer driving conditions
and works to enhance the driving experience and to eliminate accidents caused
through driver drowsiness or distraction.

There are many different sectors that can benefit from this revolutionary
software, for which it has been developed, including: automotive; academic
research; medicine/healthcare; defence; autostereoscopy (next generation
displays); sport; and games.


                      This information is provided by RNS
            The company news service from the London Stock Exchange